Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Orchestra BioMed Holdings, Inc., €19k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
John Prosper Mack: trading record in brief
This profile gathers the share dealings of John Prosper Mack in Orchestra BioMed Holdings, Inc. We count 6 filings; the first trade dates from 7 August 2024 and the latest from 12 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 14 August 2026, the filings show a share grant worth €19k in Orchestra BioMed Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Prosper Mack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,885 shares@ US$4.420.0060% mcap100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-26-097183:0
34,653 sharesCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-077767:0
3,510 sharesCommon StockSEC:0001104659-26-077767:1
15,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075785:0
12,422 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-063099:0
12,864 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-087387:0
6 of 6 declarations
